Lymphohistiocytosis Hemophagocytic

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-01-26
Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH) [Phase 2]
Phase 2 study evaluating safety and efficacy of emapalumab (anti-IFN-gamma) in patients with systemic juvenile idiopathic arthritis or adult…